- Multi-arm trial targets sub-population of advanced lung, and head and neck cancer patients- Medium term objective is to transform non-responders into checkpoint inhibitor responders while improving patient benefits- Trial aims to evaluate the ability of NBTXR3 to generate an abscopal effect- Expands the potential for NBTXR3, including recurrent...